ID: ALA259221

Max Phase: Preclinical

Molecular Formula: C6H9NO4

Molecular Weight: 159.14

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CCC(C[N+](=O)[O-])C(=O)O

Standard InChI:  InChI=1S/C6H9NO4/c1-2-3-5(6(8)9)4-7(10)11/h2,5H,1,3-4H2,(H,8,9)

Standard InChI Key:  QUESRMDDBQHDBP-UHFFFAOYSA-N

Associated Targets(Human)

Carboxypeptidase A1 146 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 159.14Molecular Weight (Monoisotopic): 159.0532AlogP: 0.54#Rotatable Bonds: 5
Polar Surface Area: 80.44Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.06CX Basic pKa: CX LogP: 0.87CX LogD: -2.26
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.36Np Likeness Score: 0.26

References

1. Wang SH, Wang SF, Xuan W, Zeng ZH, Jin JY, Ma J, Tian GR..  (2008)  Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.,  16  (7): [PMID:18289863] [10.1016/j.bmc.2008.02.010]

Source